Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Yang, Yun Liang ^a   Lin, Chih Chao ^b   Chang, Te Pin ^b   Lauderdale, Tsai Ling ^b   Chen, Hui Ting ^a,b   Lee, Ching Fu ^c   Hsieh, Chih Wen ^c   Chen, Pei Chen ^b   Lo, Hsiu Jung ^b,d  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUQUINCONAZOLE; PENCONAZOLE; TEBUCONAZOLE; TRIADIMENOL; UNCLASSIFIED DRUG; PYRROLE DERIVATIVE;

ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA TROPICALIS; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS ISOLATION; GENETIC VARIABILITY; HOST SUSCEPTIBILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SOIL ORGANISM; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN;

CANDIDA; CANDIDA TROPICALIS;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA TROPICALIS; DRUG RESISTANCE, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUCONAZOLE; HUMANS; SOIL MICROBIOLOGY; TAIWAN;

EID: 84859308650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034609     Document Type: Article

References (44)

1. Iatta R, Caggiano G, Cuna T, Montagna MT, (2011) Antifungal Susceptibility Testing of a 10-Year Collection of Candida spp. Isolated from Patients with Candidemia. J Chemother 23: 92-96.
2. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
3. Pfaller MA, Diekema DJ, Mendez M, Kibbler C, Erzsebet P, et al. (2006) Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol 44: 3551-3556.
4. Warnock DW, (2007) Trends in the epidemiology of invasive fungal infections. Nippon Ishinkin Gakkai Zasshi 48: 1-12.
5. Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, et al. (2010) The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol 48: 328-334.
6. Bard M, Bruner DA, Pierson CA, Lees ND, Biermann B, et al. (1996) Cloning and characterization of ERG25, the Saccharomyces cerevisiae gene encoding C-4 sterol methyl oxidase. Proc Natl Acad Sci U S A 93: 186-190.
7. Beck-Sague C, Jarvis WR, (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167: 1247-1251.
8. Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, et al. (2004) Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 48: 33-37.
9. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, et al. (2007) In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance. J Clin Microbiol 46: 150-156.
10. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, et al. (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 44: 747-751.
11. Pfaller MA, Diekema DJ, (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 1-53.
12. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M, (2011) Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 49: 396-399.
13. Ann Chai LY, Denning DW, Warn P, (2010) Candida tropicalis in human disease. Crit Rev Microbiol 36: 282-298.
14. Xess I, Jain N, Hasan F, Mandal P, Banerjee U, (2007) Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 35: 256-259.
15. Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ, (2004) Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 25: 60-64.
16. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA, (2004) Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53: 217-224.
17. Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, et al. (2002) Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 46: 2477-2481.
18. Lo HJ, Ho AH, Ho M, (2001) Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect 34: 171-177.
19. Chou HH, Lo HJ, Chen KW, Liao MH, Li SY, (2007) Multilocus sequence typing of Candida tropicalis shows clonal cluster enriched in isolates with resistance or trailing growth of fluconazole. Diagn Microbiol Infect Dis 58: 427-433.
20. Wang JS, Li SY, Yang YL, Chou HH, Lo HJ, (2007) Association between fluconazole susceptibility and genetic relatedness among Candida tropicalis isolates in Taiwan. J Med Microbiol 56: 650-653.
21. Li SY, Yang YL, Lin YH, Ko HC, Wang AH, et al. (2009) Two Closely Related Fluconazole-Resistant Candida tropicalis Clones Circulating in Taiwan from 1999 to 2006. Microb Drug Resist 15: 205-210.
22. Vogel C, Rogerson A, Schatz S, Laubach H, Tallman A, et al. (2007) Prevalence of yeasts in beach sand at three bathing beaches in South Florida. Water Res 41: 1915-1920.
23. Lord AT, Mohandas K, Somanath S, Ambu S, (2010) Multidrug resistant yeasts in synanthropic wild birds. Ann Clin Microbiol Antimicrob 9: 11.
24. Hung CC, Yang YL, Lauderdale TL, McDonald LC, Hsiao CF, et al. (2005) Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species. J Clin Microbiol 43: 1600-1603.
25. Prasad KN, Agarwal J, Dixit AK, Tiwari DP, Dhole TN, et al. (1999) Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B. The Indian Journal of Medical Research 110: 11-17.
26. Barchiesi F, Calabrese D, Sanglard D, Falconi DF, Caselli F, et al. (2000) Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44: 1578-1584.
27. Calvet HM, Yeaman MR, Filler SG, (1997) Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob Agents Chemother 41: 535-539.
28. Cowen LE, (2001) Predicting the emergence of resistance to antifungal drugs. FEMS Microbiol Lett 204: 1-7.
29. Cowen LE, Sanglard D, Calabrese D, Sirjusingh C, Anderson JB, et al. (2000) Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 182: 1515-1522.
30. Snelders E, Huis Veld RA, Rijs AJ, Kema GH, Melchers WJ, et al. (2009) Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol 75: 4053-4057.
31. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, et al. (2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5: e219.
32. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ, (2009) Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 9: 789-795.
33. Chen FJ, Lo HJ, (2003) Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect 36: 1-9.
34. McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, et al. (2001) Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 45: 3084-3091.
35. Yang YL, Lauderdale TL, Lo HJ, (2004) Molecular mechanisms of fluoroquinolone resistance in Klebsiella. Curr Drug Targets Infect Disord 4: 295-302.
36. Akins RA, (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43: 285-318.
37. White TC, Marr KA, Bowden RA, (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
38. Yang YL, Lo HJ, (2001) Mechanisms of antifungal agent resistance. J Microbiol Immunol Infect 34: 79-86.
39. Muller FM, Staudigel A, Salvenmoser S, Tredup A, Miltenberger R, et al. (2007) Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes. Antimicrob Agents Chemother 51: 3014-3016.
40. Lee CF, Yao CH, Liu YR, Young SS, Chang KS, (2009) Kazachstania wufongensis sp. nov., an ascosporogenous yeast isolated from soil in Taiwan. Antonie Van Leeuwenhoek 95: 335-341.
41. Yang YL, Cheng HH, Lo HJ, (2004) In vitro activity of voriconazole against Candida species isolated in Taiwan. Int J Antimicrob Agents 24: 294-296.
42. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, et al. (2008) Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn Microbiol Infect Dis 61: 175-180.
43. Clinical Laboratory Standards Institute CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3. Wayne, PA.
44. Chen KW, Lo HJ, Lin YH, Li SY, (2005) Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 54: 249-258.